Pharma Marketing Network

AUGUST 9, 2023

The pharmaceutical industry operates in a highly regulated environment, where marketing and advertising practices are subject to rigorous scrutiny. Navigating these regulatory challenges is essential to ensure compliance, maintain trust, and effectively communicate the benefits and risks of pharmaceutical products.

Marketing 52

Marketing Pharma Food and Drug Administration Media 52

European Pharmaceutical Review

MARCH 12, 2024

Regulatory bodies such as the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) place great importance on data integrity in the pharmaceutical/life science industry. Blockchain technology creates a decentralised and unalterable ledger that records all transactions across a network of computers.

Government 85

Government Pharma Ethics Training 85

Pharma Marketing Network

AUGUST 9, 2023

The pharmaceutical industry operates in a highly regulated environment, where marketing and advertising practices are subject to rigorous scrutiny. Navigating these regulatory challenges is essential to ensure compliance, maintain trust, and effectively communicate the benefits and risks of pharmaceutical products.

Marketing 40

Marketing Pharma Food and Drug Administration Media 40

eMediWrite

MAY 10, 2022

You may boost your pharma social media marketing and strengthen your business by following these techniques. The pharmaceutical business, on the other hand, is operating at full capacity. The pharma market is expected to be fiercely competitive in 2021 due to a rise in the number of people who require medication. ENSURE SAFETY.

Media 52

Media Marketing Pharma Safety 52

PharmaKinnex

AUGUST 23, 2022

The Traditional Pharma Model Isn’t Working – It’s Time to Evolve! The pharmaceutical industry of 2022 is very different from the space that we all knew in 2012, 2016, or even 2020. What are these new and existing pharma regulations, expectations, and challenges? COVID-19, Telemedicine, & The New Pharma Landscape.

Pharma 52

Pharma Sales Sales Strategy Marketing 52

pharmaphorum

SEPTEMBER 28, 2022

Payers must take into consideration not only the clinical efficacy of a drug, but also its safety profile, side effects, and cost-effectiveness, among other factors. There are several barriers that can negatively impact HTA and pricing outcomes, including uncertainty and trials that are not designed with the payers’ evidence needs in mind.

Biopharma 52

Biopharma Side effects Consulting Pharmaceutical products 52

European Pharmaceutical Review

JULY 25, 2022

In fact, the most recent estimate from the World Customs Organization places the global fake pharma market at $200 billion. Frustratingly, it is the very challenges fuelling the fake medicines market that fraudulent products also seem to exacerbate – global health inequalities. But what exactly does this look like? .

Pharmaceutical 80

Pharmaceutical Medicine Pharmaceutical manufacturing Manufacturing 80